Skip to content

Japan logo

Main menu
    • オルガノンについて
    • 私たちの想い
    • 会社概要
    • 事業・製品
    • カルチャー
    • プレスリリース
    • プロジェクト
    • メディア掲載/受賞
    • 病気とくすりの情報
    • オルガノン製品情報
    • 医療従事者向け製品情報サイト「ORGANON PRO」
    • 採用情報
    • オルガノンでの働き方、制度
    • オルガノンで働く社員

お問い合わせ

Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
top_mv_0913_A

すべての女性に、より豊かで、より健やかな毎日を。

お知らせ

2025/06/30

メディア掲載

企業・行政・社会が共創する、これからの不妊治療支援と女性のヘルスケア | Business Insider Japan

2025/04/01

プレスリリース

代表取締役社長交代のお知らせ

2025/02/21

メディア掲載

厚生労働省の「特別休暇制度導入事例集2024」に掲載されました。

2024/09/04

プレスリリース

月経困難症治療薬候補OG-8276A 国内第三相臨床試験で主要評価項目を達成

2024/06/11

メディア掲載

東京都が運営する「働く女性のウェルネス向上委員会」ウェブサイトの企業事例に掲載されました。

2024/06/04

プロジェクト

「女性の健康とキャリアに関する調査白書」を公開しました。

オルガノンについて

「すべての女性に、より豊かで、より健やかな毎日を。」私たちオルガノンは、この願いをかなえるために生まれたヘルスケア企業です。

もっと見るボタン

事業・製品

私たちは、ウィメンズヘルスを事業の中核に据えながら、長期ブランド製品やバイオシミラー事業に注力し、60以上の製品を、世界140カ国以上の患者さまへお届けしています。

もっと見るボタン

採用情報

「すべての女性がより豊かで、より健やかな毎日を。」というビジョンに共感し、情熱を持って共に歩んでくださる方を募集しています。

もっと見るボタン

Connect with us on social

Linkedin icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Japan logo
  • 将来に関する記述
  • クッキーポリシー
  • プライバシーポリシー
  • 利用条件
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept